Patents
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
06/2003
06/05/2003US20030104974 Dual inhibitorsof PDE 7 and PDE 4
06/05/2003US20030104081 Composition for treating obesity and esthetic treatment process
06/04/2003EP1315728A1 Process for the preparation of vitronectin receptor antagonists
06/04/2003CN1110496C Tetrahydro Gamma-carbolines compound
06/03/2003US6573378 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine having a purity of greater than 95% by weight or it's sodium salt
06/03/2003US6573044 Methods of using chemical libraries to search for new kinase inhibitors
05/2003
05/29/2003US20030100574 Tricyclic 3,4-propinoperhydropurines; uses thereof for blocking neuronal transmission
05/29/2003US20030100571 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease
05/29/2003US20030100546 Neuropeptide Y antagonists
05/29/2003US20030099686 Theobromine with an anti-carcinogenic activity
05/28/2003EP1313737A1 Novel guanidino derivatives as inhibitors of cell adhesion
05/28/2003EP1231211B1 Thiazolidinedione derivatives as antidiabetic agents
05/28/2003CN1420887A 8-quinolinxanthine and 8-isoquinolinxanthine derivs. as PDE 5 inhibitors
05/28/2003CN1109675C Arylpyrimidine derivs.
05/27/2003US6569869 Annulated azole derivatives useful as microbicidal agents
05/22/2003WO2003042214A2 A2b adenosine receptor antagonists
05/22/2003WO2003042185A1 Xanthine oxidase inhibitors
05/22/2003WO2003041647A2 Synthesis and purification of valacyclovir
05/22/2003WO2003041642A2 Polymeric thiol-linked prodrugs employing benzyl elimination systems
05/22/2003US20030096858 The parent drug compound is modified by forming one or more of predetermined chemical arrangement within parent drug structure for programming specific course and rate of metabolism for drug that leads to inactive nontoxic metabolite
05/22/2003US20030096836 2-Aroylimidazole compounds for treating cancer
05/22/2003US20030096788 Adenosine derivatives
05/22/2003US20030095992 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots
05/22/2003CA2649826A1 Synthesis and purification of valacyclovir
05/21/2003EP1311268A1 Imidazopyridine and imidazopyrimidine antiviral agents
05/21/2003EP0784974B1 preparation of xanthine derivatives in a solid dispersion
05/21/2003CN1419450A Nitrite salts of antimicrobial agents
05/21/2003CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
05/21/2003CN1108796C Use of anticancer material and production method of said anti-cancer material
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566381 For therapy of arthritis, cancer, cardiovascular disorder, skin disorder, ocular disorder, inflammation and gum disease
05/20/2003CA2144962C 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistant cancer cell sensitizers
05/15/2003WO2003040145A1 Anhydrous crystal form of valaciclovir hydrochloride
05/15/2003WO2003040144A2 Heterocyclic compound based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003US20030092909 Cyclin-dependent kinase inhibitor; antitumor, anticancer agents
05/15/2003US20030092908 Autoimmune diseases; rheumatic diseases; multiple sclerosis; inflammatory bowel disease; immunosuppressants
05/15/2003US20030092721 Antiinflammatory agents; rheumatic diseases
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2465420A1 Anhydrous crystal form of valaciclovir hydrochloride
05/14/2003EP1310507A2 Novel peptide nucleic acids
05/14/2003EP1192170B1 Propargyl phenyl ether a2a receptor agonists
05/14/2003CN1418111A Novel Ligands and method for preparing same
05/13/2003US6562969 Ricin inhibitors and methods for use thereof
05/13/2003US6562819 Compounds for inhibition of ceramide-mediated signal transduction
05/13/2003CA2021467C Heterocyclically substituted sulfonylureas, process for their preparation, and their use as herbicides or plant growth regulators
05/08/2003WO2003037860A2 Purine analogs having hsp90-inhibiting activity
05/08/2003WO2002094740A8 Hydrogenation processes performed in ionic liquids
05/08/2003US20030087918 Substituted with purine or pyrimidine bases
05/08/2003US20030087906 Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents
05/08/2003US20030087904 Xanthine derivatives, such as 3-isobutyl-8-pyrrolidinylxanthine; treating asthma, diarrhea, etc.
05/08/2003US20030087873 Treating a Flaviviridae, Orthomyxoviridae or Paramyxoviridae infection
05/08/2003CA2464031A1 Purine analogs having hsp90-inhibiting activity
05/07/2003EP1308447A1 Purine derivatives having antiproliferative properties and biological uses thereof
05/07/2003EP0912520B1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
05/06/2003US6559313 Adenosine derivatives such as (1S,2R,3S,4R)-2,3-dihydroxy-4-(6-(1-(4-trifluormethylpyridin-2-yl)pyrrolidin-3(S)-yl-amino)purin-9-yl)cyclopentanecarboxylic acid isopropylamide
05/06/2003US6559293 Topiramate sodium trihydrate
05/02/2003EP1306378A1 Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient
05/02/2003EP1305290A1 Novel heteroaryl derivatives and the use thereof as pharmaceuticals
05/02/2003EP1305028A2 Antimicrobial biaryl compounds
05/02/2003EP1305026A2 Barbituric acid analogs as therapeutic agents
05/02/2003EP1305023A1 Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis
05/01/2003WO2003035075A1 Inhibitors of human phosphatidyl-inositol 3-kinase delta
05/01/2003WO2003035009A2 Treatment of acute myeloid leukemia with indolinone compounds
05/01/2003WO2002072581A3 Pyrazolopyriadine derivatives
05/01/2003US20030083518 Substituted alcohols useful in treatment of Alzheimer's disease
05/01/2003US20030083327 Inhibitors of Aurora-2 protein kinases and Glycogen synthase kinase-3 (GSK-3); cancer, diabetes, Alzheimer's disease, and schizophrenia treatment
05/01/2003US20030079311 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle
05/01/2003CA2464790A1 Treatment of acute myeloid leukemia with indolinone compounds
04/2003
04/29/2003US6555687 Chloropyrimidine intermediates
04/29/2003US6555685 Preparing purine derivatives, such as famiciclovir and penciclovir, by reacting, in the presence of a palladium catalyst and ligand; by-product inhibition; efficiency
04/29/2003US6555572 Benzylated PDE4 inhibitors
04/29/2003US6555545 Adenosine, caffeine, and 8-styryl-1,3,7-alkyl xanthine derivatives as wound healing agents
04/24/2003WO2003033498A2 A process for the treatment of ganciclovir intermediate n2-acetyl-9-(1, 3-diacetoxy-2-propoxymethyl) guanine
04/24/2003WO2003032989A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
04/24/2003WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003WO2002045707A3 Polynucleotide intercalator interceptors and inhibitors
04/24/2003US20030078275 For therapy of cancer, diabetes and Alzheimer's disease
04/24/2003US20030078166 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003CA2462441A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
04/23/2003EP1304046A1 Theobromine with an anti-carcinogenic activity
04/23/2003EP1303641A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
04/23/2003EP1220863B1 Purine derivatives
04/23/2003CN1413216A Azolyalkyl-oxa (di) azolyl pyri (mi) dine derivatives, method for their production and use as pesticides
04/23/2003CN1411813A Theobromine with anticancer activity
04/22/2003US6552193 Chloropyrimidine intermediates
04/22/2003US6552192 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
04/22/2003US6552073 Compounds and methods of treating cell proliferative diseases
04/22/2003CA2239187C Inhibitors of farnesyl protein transferase
04/17/2003WO2003031406A2 Kinase inhibitor scaffolds and methods for their preparation
04/17/2003WO2003031405A2 Methods for the synthesis of substituted purines
04/17/2003US20030073834 Purine compounds having PDE IV inhibitory activity and methods of synthesis
04/17/2003US20030073687 Alzheimer's disease; anticancer agents; antidiabetic agents
04/17/2003US20030072965 Electroluminescence device for use in display devices, backlights, electro-photographies, illumination light sources, recording light sources, exposing light sources, reading light sources, road signs and markings, optical communication
04/17/2003CA2463563A1 Kinase inhibitor scaffolds and methods for their preparation
04/17/2003CA2463507A1 Methods for the synthesis of substituted purines
04/16/2003EP1301829A1 Radiation sensitive compositions containing image quality and profile enhancement additives
04/16/2003EP1301187A2 Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv
04/16/2003EP1150981B1 Use of (1r, 4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol in hbv
04/16/2003EP0674634B1 Process for preparing substituted 1,3-oxathiolanes with antiviral properties
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 120